| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87536 |
|
5,464 |
5,029 |
$399K |
| 86360 |
|
5,427 |
4,993 |
$218K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,210 |
2,051 |
$99K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,345 |
2,194 |
$49K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,690 |
5,206 |
$37K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
807 |
768 |
$35K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
533 |
490 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
218 |
215 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
590 |
543 |
$4K |
| 80061 |
Lipid panel |
250 |
189 |
$2K |
| 87522 |
Neg quan hep c or qual rna |
56 |
48 |
$2K |
| 80053 |
Comprehensive metabolic panel |
242 |
197 |
$2K |
| 85027 |
|
186 |
183 |
$1K |
| 81000 |
|
320 |
279 |
$700.09 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
41 |
28 |
$548.69 |
| 84443 |
Thyroid stimulating hormone (TSH) |
71 |
57 |
$512.53 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16 |
13 |
$470.79 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
13 |
$470.79 |
| 86769 |
|
17 |
17 |
$370.14 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25 |
13 |
$230.40 |
| 86738 |
|
13 |
13 |
$105.36 |
| 82043 |
|
44 |
44 |
$105.13 |
| 82570 |
|
16 |
16 |
$67.96 |
| 86592 |
|
17 |
14 |
$55.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17 |
12 |
$41.53 |